Do you want to be able to anticipate and mitigate adverse drug reactions through machine learning?
Lhasa has developed a privacy-preserving data sharing solution, Effiris.
Effiris members observed a 5-15% improvement in MCC across their internal hERG data when using the Hybrid Effiris model, in comparison with a model trained using private data alone!
View this infographic for more detail.